Gras Navarro, A., Kmiecik, J., Leiss, L., Zelkowski, M., Engelsen, A., Bruserud, Ø., . . . Chekenya, M. (2014). NK Cells with KIR2DS2 Immunogenotype Have a Functional Activation Advantage To Efficiently Kill Glioblastoma and Prolong Animal Survival. J Immunol.

Gras Navarro, Andrea, Justyna Kmiecik, Lina Leiss, Mateusz Zelkowski, Agnete Engelsen, Øystein Bruserud, Jacques Zimmer, Per Øyvind Enger, and Martha Chekenya. "NK Cells With KIR2DS2 Immunogenotype Have a Functional Activation Advantage To Efficiently Kill Glioblastoma and Prolong Animal Survival." J Immunol 2014.

Gras Navarro, Andrea, et al. "NK Cells With KIR2DS2 Immunogenotype Have a Functional Activation Advantage To Efficiently Kill Glioblastoma and Prolong Animal Survival." J Immunol 2014.